A Study to Evaluate JL18008 in Subject With HIV Immunological Non-Responders

NCT07579741 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

NOT_YET_RECRUITING

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: JL18008 20 μg/kg
DRUG: Placebo (for 20 μg/kg Group)
DRUG: JL18008 40 μg/kg
DRUG: Placebo (for 40 μg/kg Group)
DRUG: JL18008 70 μg/kg
DRUG: Placebo (for 70 μg/kg Group)

Sponsor

Jecho Biopharmaceuticals Co., Ltd.